Top 35 CleanTech Startup Investors in Oceania in January 2025

Icehouse Ventures is an early-stage venture capital firm. We exist to back the world's bravest Kiwi founders, launching global companies from New Zealand.

We work with inventors who are building something hard from their unique expertise in science. These inventors are building the industries that will thrive for the decades to come. We have a unique working model to accelerate a company's pathway to scale.

Build your next company with Antler, a global day zero investor enabling exceptional founders to start great companies, from the very beginning. Apply now!

Uninhibited Venture Investing Southeast Asia & Australia-New Zealand

K1W1 provides startups and businesses in New Zealand with early and later-stage venture investments.

We are a community-powered VC fund making pre-seed / seed stage investments in Australian and New Zealand startups. Our community is rallied around a shared goal: to invest in the next generation of Australia and New Zealand startups at the very earliest stage, and then support them on their long a

Working on something fresh. Also, Partner @Acceleprise & columnist @TheNextWeb.

Uniseed was established in October 2000 as a $20 million joint venture between the University of Melbourne (UM) and the University of Queensland (UQ). This proof of concept fund (Fund-1) operated with significant input and support from the commercialization offices of the two universities (UniQuest and Melbourne Ventures Limited), with staff ofthese organizations making up the majority of the Investment Committee and leading due diligence and management of most investment opportunities. Over 20 investments, typically of $250,000 - $500,000 were made from this fund.A new $40 million venture fund (Fund-2) ran from 2005-15, with the addition of a third leading university, the University of New South Wales, and a major private institutional investor, the Westscheme superannuation fund. The founding universities (UQ & UM) also committed further funds. Australian Super took over Westscheme's essets and commitments in July 2011.With the start of Fund-2, an independent management team was established, consisting of the CEO and three Investment Managers; one at each university catchment. The Investment Committee was restructured, with dedicated committees established for biotechnology or other technologies. The nominal investment limit was increased to $2.5 million to allow participation in follow-on funding rounds so as to preserve Uniseed's equity position.On 1 November 2015, Uniseed started its third and largest fund (Fund-3) with the addition of the University of Sydney and the CSIRO to the Universities of Queensland, Melbourne and NSW. This followed three high profile exits in the preceding 14 months (Fibrotech; Spinifex & Hatchtech). Each of the five partners committed $10 million over 10 years to the new fund (total fund $50 million).Uniseed’s partner research organisations spent nearly $4 billion on research, making up over 40% of the total research spend at 67 research organisations in Australia. Together, these organisations accounted for nearly 500 invention disclosures (34% of total) and 500 new registered IP rights filed (45% of total) over the same period(2013 National Survey of Research Commercialisation). Unlike private venture capital funds, Uniseed is dedicated to the needs of its research partners, and committed to servicing them consistently over the long term, irrespective of the short term conditions in external capital markets. It works in very close partnership with the research partner commercialisation companies and staff, providing a valuable adjunct to the capabilities these companies and staff provide. They in turn provide a best-practice commercialisation service tailored to their respective organisations. These companies are able to leverage to great effect the scale of operation and expertise of the Uniseed network.The fund is run with commercial discipline, ensuring independence and financial rigor in its investment decision-making processes. Success is measured by a balance of return on investment (including the flow of funds for research to further the commercialisation of intellectual property generated within the research partner catchments), the establishment of viable start-up companies, the generation of research income for research partners and the improvement of partner commercialisation processes.

Early stage Venture Capital firm based in Brisbane that's investing in next generational Australian companies that are building a better future.

Common Sense Ventures is an Australian family office backing early-stage, fast-growing businesses. We partner with ambitious managers looking to solve problems that will help the world.

Uniseed was established in October 2000 as a $20 million joint venture between the University of Melbourne (UM) and the University of Queensland (UQ). This proof of concept fund (Fund-1) operated with significant input and support from the commercialization offices of the two universities (UniQuest and Melbourne Ventures Limited), with staff ofthese organizations making up the majority of the Investment Committee and leading due diligence and management of most investment opportunities. Over 20 investments, typically of $250,000 - $500,000 were made from this fund.A new $40 million venture fund (Fund-2) ran from 2005-15, with the addition of a third leading university, the University of New South Wales, and a major private institutional investor, the Westscheme superannuation fund. The founding universities (UQ & UM) also committed further funds. Australian Super took over Westscheme's essets and commitments in July 2011.With the start of Fund-2, an independent management team was established, consisting of the CEO and three Investment Managers; one at each university catchment. The Investment Committee was restructured, with dedicated committees established for biotechnology or other technologies. The nominal investment limit was increased to $2.5 million to allow participation in follow-on funding rounds so as to preserve Uniseed's equity position.On 1 November 2015, Uniseed started its third and largest fund (Fund-3) with the addition of the University of Sydney and the CSIRO to the Universities of Queensland, Melbourne and NSW. This followed three high profile exits in the preceding 14 months (Fibrotech; Spinifex & Hatchtech). Each of the five partners committed $10 million over 10 years to the new fund (total fund $50 million).Uniseed’s partner research organisations spent nearly $4 billion on research, making up over 40% of the total research spend at 67 research organisations in Australia. Together, these organisations accounted for nearly 500 invention disclosures (34% of total) and 500 new registered IP rights filed (45% of total) over the same period(2013 National Survey of Research Commercialisation). Unlike private venture capital funds, Uniseed is dedicated to the needs of its research partners, and committed to servicing them consistently over the long term, irrespective of the short term conditions in external capital markets. It works in very close partnership with the research partner commercialisation companies and staff, providing a valuable adjunct to the capabilities these companies and staff provide. They in turn provide a best-practice commercialisation service tailored to their respective organisations. These companies are able to leverage to great effect the scale of operation and expertise of the Uniseed network.The fund is run with commercial discipline, ensuring independence and financial rigor in its investment decision-making processes. Success is measured by a balance of return on investment (including the flow of funds for research to further the commercialisation of intellectual property generated within the research partner catchments), the establishment of viable start-up companies, the generation of research income for research partners and the improvement of partner commercialisation processes.

Carthona Capital is a hands-on, proactive, and thematic venture capital investor based in Sydney, Australia that invests globally.

Applied Ventures, LLC, is the venture capital arm of Applied Materials, Inc., (NASDAQ: AMAT) investing in innovative startups for over a decade.

At Vulpes, we think differently. We create long-term sustainable capital appreciation by welcoming co-investment and aligning incentives. We choose to be patient and invest in ways that are profitable, yet with benefits that are not solely financial.

AES provides affordable and reliable energy to customers around the world through its distribution businesses and thermal and renewable power generation facilities. With more than 30 years of experience, diverse mix of generation and utility sources provides the strength and flexibility to adapt to local and regional market needs, maximize plantefficiency and deliver reliable, affordable electricity.

Cyan Ta'eed was born in Sydney, Australia. She worked as a graphic designer before co-founding Envato in 2006 with her husband, Collis Ta'eed, and his best friend, Jun Rung. She now serves on Envato's Board of Directors. Cyan Ta'eed is also the co-creator of New Day Box, a charity focusing on women in crisis.

Wavemaker Group is a cross-border venture capital firm founded in 2003 and one of the most active early-stage investors across multiple funds.

5 Pillars Capital is an investment firm.

invest in companies and protocols that challenge the existing norms and push for the next frontier of digital innovation.

Cemex Ventures is the corporate venture capital of Cemex. With a global focus, we invest in, accelerate, and partner with innovative startups to drive the construction revolution.

Lewis Holdings was added in 2013.

Black Kite Capital is a single-family investment office based in Singapore.

Australia's only truly global early stage VC, we believe in and back the most ambitious founders from the earliest stage.

Everywhere Ventures (fka "The Fund") is a first-of-its-kind early-stage venture fund created ​by founders for founders​ to support the next generation of entrepreneurs.Everywhere Ventures is a community-powered venture investing platform that integrates the capital, expertise, and mentoring of experienced founders and operators acrossten micro funds. The Fund's $70M+ under management comes almost exclusively from the over 500 founders and operators who are its limited partners. Everywhere Ventures operates from the belief that those who have actually built successful companies are best suited to advise and support early-stage startups. Everywhere Ventures invests in pre-seed deals globally usually in the first financing round the company raises. Emphasis is placed on purpose-driven teams across money, health and work verticals.

Marbruck is an open-ended venture capital group. Marbruck sources, invests, and provides ongoing guidance to early / growth stage technology companies. With no outside capital, Marbruck actively manages a diverse global portfolio of 30+ companies spanning Seed through to pre-listing. Marbruck leverages its intellectual capital, its network ofpartner investors, and its deep operational experience, to successfully navigate the highest-risk, highest-reward spectrum of investing.

Investing in great people solving hard problems to create a better future.

Simon Sheikh

Bandera Capital offers financial modeling, valuation analysis, strategy consulting, and investment advisory services to businesses.

Championing the next generation of B2B technology startups.

Everywhere Ventures (fka "The Fund") is a first-of-its-kind early-stage venture fund created ​by founders for founders​ to support the next generation of entrepreneurs.Everywhere Ventures is a community-powered venture investing platform that integrates the capital, expertise, and mentoring of experienced founders and operators acrossten micro funds. The Fund's $70M+ under management comes almost exclusively from the over 500 founders and operators who are its limited partners. Everywhere Ventures operates from the belief that those who have actually built successful companies are best suited to advise and support early-stage startups. Everywhere Ventures invests in pre-seed deals globally usually in the first financing round the company raises. Emphasis is placed on purpose-driven teams across money, health and work verticals.

Black Nova Group provide services across investment & venture capital.

OneVentures is one of Australia’s leading venture capital firms, with over $330M in funds under management. But they do more than invest. They take companies to that all important next stage, by actively shaping their future. They apply their years of international experience, operational and executional expertise to accelerate the growth of theirportfolio companies. A global growth focus drives their investment selection with their current portfolio including companies with truly innovative products tackling multi-billion-dollar problems, from needle-free vaccinations to virtual communications to adaptive e-learning.

Catalysing smart monies into Singapore-based, early-stage technology startups.

Brian was appointed Managing Director & CEO in February 2015. Brian joined Westpac as Chief Executive, Australian Financial Services in June 2012 encompassing Westpac Retail & Business Banking, St.George Banking Group and BT Financial Group.Brian was appointed Chairman of the Australian Bankers' Association in February 2015. Priorto joining Westpac, Brian spent three years in the UK as CEO for Retail, Wealth and Ulster Bank at the Royal Bank of Scotland Group. Prior to that, he spent ten years with Australia and New Zealand Banking Group Limited (ANZ) in Australia in a variety of roles, including his final role as CEO, Australia and Global Segment Lead for Retail and Wealth. Before joining ANZ, Brian spent ten years as a financial services consultant in New York, San Francisco, and Melbourne. Brian graduated from Princeton University with a degree in European History and is a Chartered Financial Analyst.

Trading with bright minds and bold ambitions.